ELAN PEER ANALYSIS

Elanco Animal Health — metric-by-metric comparison with peers and the industry median

ELANElanco Animal Health

🇺🇸 USA · NYSE · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

ELANIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ELAN	ROVI	MRK	BHC	ECILC	GENIL	Ind. Median
P/E	—	22.16●	24.51	—	—	46.82	21.35
P/B	1.96	4.33	2.09	-0.87●	0.80	3.47	1.77
EV/EBITDA	21.31	14.69	11.78	4.05●	33.84	14.07	12.18
P/S	2.60	3.94	2.96	0.20●	5.03	1.86	2.08

Financial Health
Metric	ELAN	ROVI	MRK	BHC	ECILC	GENIL	Ind. Median
Current Ratio	2.16	3.66●	1.51	1.32	1.73	1.33	2.22
Debt/Equity	61.4%	17.0%	40.5%	-1,010.0%●	5.9%	41.0%	46.3%
NetDebt/EBITDA	4.66	0.09	1.38	3.71	-0.10●	1.10	1.24

Profitability
Metric	ELAN	ROVI	MRK	BHC	ECILC	GENIL	Ind. Median
Net Margin	-4.9%	17.8%●	12.1%	-13.5%	-3.6%	4.0%	4.0%
ROE	-3.8%	20.9%●	8.5%	—	-0.6%	8.7%	6.4%
ROA	-1.8%	15.1%●	4.9%	-4.7%	-0.5%	4.8%	3.4%
EBITDA Margin	15.6%	27.0%	28.5%	60.0%●	14.8%	14.3%	18.2%

Growth + Dividend
Metric	ELAN	ROVI	MRK	BHC	ECILC	GENIL	Ind. Median
Rev. Growth	10.5%	-3.4%	-1.7%	-9.9%	-2.3%	16.3%●	7.5%
NI Growth	—	-5.9%	-10.1%	—	—	146.6%●	5.0%
Div. Yield	—	1.6%	1.5%	0.0%	2.6%●	0.0%	2.0%
Payout	—	36.3%	11.8%	0.0%	-365.1%	0.0%	0.8%

Valuation
Metric	ELAN	ALKS	NBIX	HIMS	VTRS	LQDA	Ind. Median
P/E	—	60.01	26.92●	—	—	359.07	21.35
P/B	1.96	5.23	5.28	19.59	1.35●	73.76	1.77
EV/EBITDA	21.31	37.03	17.88	303.51	12.59●	148.18	12.18
P/S	2.60	5.87	5.80	3.69	1.36●	27.80	2.08

Financial Health
Metric	ELAN	ALKS	NBIX	HIMS	VTRS	LQDA	Ind. Median
Current Ratio	2.16	2.27	2.93●	1.69	1.60	2.22	2.22
Debt/Equity	61.4%	90.3%	11.9%●	253.7%	97.9%	170.2%	46.3%
NetDebt/EBITDA	4.66	3.87	-0.95●	12.68	4.89	-0.71	1.24

Profitability
Metric	ELAN	ALKS	NBIX	HIMS	VTRS	LQDA	Ind. Median
Net Margin	-4.9%	9.8%	21.6%●	-0.6%	-2.0%	7.7%	4.0%
ROE	-3.8%	9.4%	22.5%	-2.7%	-2.0%	28.2%●	6.4%
ROA	-1.8%	4.8%	15.6%●	-0.8%	-0.8%	7.1%	3.4%
EBITDA Margin	15.6%	17.7%	30.8%●	1.3%	17.6%	18.7%	18.2%

Growth + Dividend
Metric	ELAN	ALKS	NBIX	HIMS	VTRS	LQDA	Ind. Median
Rev. Growth	10.5%	3.2%	28.6%	32.8%	1.6%	1,936.7%●	7.5%
NI Growth	—	-56.7%	118.6%●	—	—	—	5.0%
Div. Yield	—	—	—	—	3.0%	—	2.0%
Payout	—	—	—	—	-188.0%	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ELAN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.